| BGLAP |
BGLAP: Osteocalcin precursor |
TACR2 |
TACR2, NK2R, NKNAR, TAC2R: Substance-K receptor |
1.325 |
Evidence |
|
| BGLAP |
BGLAP: Osteocalcin precursor |
ITIH1 |
ITIH1, IGHEP1: Inter-alpha-trypsin inhibitor heavy chain H1 precursor |
1.325 |
Evidence |
|
| BGLAP |
BGLAP: Osteocalcin precursor |
DRD2 |
DRD2: D(2) dopamine receptor |
1.325 |
Evidence |
|
| BGLAP |
BGLAP: Osteocalcin precursor |
F5 |
F5: Coagulation factor V precursor |
1.325 |
Evidence |
|
| BGLAP |
BGLAP: Osteocalcin precursor |
CHRM2 |
CHRM2: Muscarinic acetylcholine receptor M2 |
1.325 |
Evidence |
|
| BGLAP |
BGLAP: Osteocalcin precursor |
RHO |
RHO, OPN2: Rhodopsin |
1.325 |
Evidence |
|
| FN1 |
IPI00339223 |
KLK6 |
KLK6, PRSS18, PRSS9: Kallikrein-6 precursor |
1.325 |
Evidence |
|
| FN1 |
IPI00339223 |
HPN |
HPN, TMPRSS1: Serine protease hepsin |
1.325 |
Evidence |
|
| FN1 |
IPI00339223 |
F11 |
F11: Coagulation factor XI precursor |
1.325 |
Evidence |
|
| FN1 |
FN1, FN: Fibronectin precursor |
EFNA1 |
EFNA1, EPLG1, LERK1, TNFAIP4: Ephrin-A1 precursor |
1.325 |
Evidence |
|
| HLA-DRB2 |
HLA class II histocompatibility antigen, DW2.2/DR2.2 beta chain (Fragment) |
B2M |
B2M, CDABP0092, HDCMA22P: Beta-2-microglobulin precursor [Contains: Beta-2-micro |
1.325 |
Evidence |
|
| HLA-DRA |
HLA-DRA, HLA-DRA1: HLA class II histocompatibility antigen, DR alpha chain precu |
B2M |
B2M, CDABP0092, HDCMA22P: Beta-2-microglobulin precursor [Contains: Beta-2-micro |
1.325 |
Evidence |
|
| HLA-A |
HLA-A, HLAA: HLA class I histocompatibility antigen, A-68 alpha chain precursor |
B2M |
B2M, CDABP0092, HDCMA22P: Beta-2-microglobulin precursor [Contains: Beta-2-micro |
1.325 |
Evidence |
|
| IGHA1 |
IPI00719411 |
B2M |
B2M, CDABP0092, HDCMA22P: Beta-2-microglobulin precursor [Contains: Beta-2-micro |
1.325 |
Evidence |
|
| IGHG3 |
IPI00642082 |
B2M |
B2M, CDABP0092, HDCMA22P: Beta-2-microglobulin precursor [Contains: Beta-2-micro |
1.325 |
Evidence |
|
| VIP |
VIP: VIP peptides precursor [Contains: Intestinal peptide PHV-42; Intestinal pep |
GPR116 |
GPR116, KIAA0758: Probable G-protein coupled receptor 116 precursor |
1.325 |
Evidence |
|
| VIP |
VIP: VIP peptides precursor [Contains: Intestinal peptide PHV-42; Intestinal pep |
GPR126 |
DREG: Developmentally regulated G-protein-coupled receptor alpha 1 |
1.325 |
Evidence |
|
| VIP |
VIP: VIP peptides precursor [Contains: Intestinal peptide PHV-42; Intestinal pep |
CALCRL |
CALCRL, CGRPR: Calcitonin gene-related peptide type 1 receptor precursor |
1.325 |
Evidence |
|
| VIP |
VIP: VIP peptides precursor [Contains: Intestinal peptide PHV-42; Intestinal pep |
SCTR |
SCTR: Secretin receptor precursor |
1.325 |
Evidence |
|
| GCG |
GCG: Glucagon precursor [Contains: Glicentin; Glicentin-related polypeptide |
GPR116 |
GPR116, KIAA0758: Probable G-protein coupled receptor 116 precursor |
1.325 |
Evidence |
|
| GCG |
GCG: Glucagon precursor [Contains: Glicentin; Glicentin-related polypeptide |
GPR126 |
DREG: Developmentally regulated G-protein-coupled receptor alpha 1 |
1.325 |
Evidence |
|
| GCG |
GCG: Glucagon precursor [Contains: Glicentin; Glicentin-related polypeptide |
SCTR |
SCTR: Secretin receptor precursor |
1.325 |
Evidence |
|
| EGF |
EGF: Pro-epidermal growth factor precursor |
YLPM1 |
IPI00165434 |
1.325 |
Evidence |
|
| AGT |
AGT, SERPINA8: Angiotensinogen precursor |
F7 |
F7: Coagulation factor VII precursor |
1.325 |
Evidence |
|
| SERPINA1 |
SERPINA1, AAT, PRO0684, PI, PRO2209: Alpha-1-antitrypsin precursor |
F7 |
F7: Coagulation factor VII precursor |
1.325 |
Evidence |
|